Leica Biosystems PD-L1 BOND antibody
Leica Biosystems’ PD-L1 BOND antibody is designed for use on the company’s fully automated BOND IHC and ISH staining platform.
The PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by Abcam on behalf of Merck KGaA, which owns all IP rights to this antibody. It joins the ALK (anaplastic lymphoma kinase) antibody as the latest addition to Novocastra’s growing lung menu of primary antibodies.
Leica Biosystems has optimised these two clones into a ready-to-use format for use on the BOND IHC and ISH staining platform. This allows labs to perform ALK and PD-L1 testing on the BOND system with rapid turnaround times, reliable staining and walk-away convenience.
Phone: 1800 625 286
Antibodies Inc Recombinant Antibodies
Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.
AdipoGen Immune Checkpoint Reagents for Immuno-Oncology Research
AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...
AdipoGen Life Sciences Isthmin-1
AdipoGen Life Sciences' Isthmin-1 (human) ELISA Kit is designed to provide specific...
